Teva’s stock has tumbled over 8 sessions and Morgan Stanley says it could fall 16% more
August 07, 2017 at 13:18 PM EDT
Teva’s corporate troubles have been exacerbated by wider generic drug industry challenges.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|